Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies
Journal:
Current Topics in Medicinal Chemistry
Volume:
24
Page:
1185-1211
Author(s):
Seyed Morteza Naghib* and Kave Mohammad-Jafari
Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
3502-3528
Author(s):
Pooja Kumari, Narasimha Murthy Beeraka, Anandkumar Tengli*, Gurupadayya Bannimath, Ramandeep Kaur Baath and Mayuri Patil
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease
Journal:
Current Alzheimer Research
Volume:
21
Page:
50-68
Author(s):
Kushagra Nagori, Madhulika Pradhan, Mukesh Sharma, Ajazuddin, Hemant R. Badwaik and Kartik T. Nakhate*
Genetic Factors and MicroRNAs in the Development of Gallbladder Cancer: The Prospective Clinical Targets
Journal:
Current Drug Targets
Volume:
25
Page:
375-387
Author(s):
Roshni Quraishi, Somali Sanyal, Medha Dwivedi, Monika Moitra and Manish Dwivedi*
Identification of Prognostic Markers and Potential Therapeutic Targets using Gene Expression Profiling and Simulation Studies in Pancreatic Cancer
Journal:
Current Computer-Aided Drug Design
Volume:
20
Page:
955-973
Author(s):
Samvedna Singh, Aman Chandra Kaushik, Himanshi Gupta, Divya Jhinjharia and Shakti Sahi*
TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
3397-3411
Author(s):
Guangyi Liu, Huan Wang, Rui Ran, Yicheng Wang and Yang Li*
PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
3265-3285
Author(s):
Adriana Romo-Perez, Guadalupe Domínguez-Gómez, Alma D. Chávez-Blanco, Aurora González-Fierro, José Correa-Basurto and Alfonso Dueñas-González*
Mechanism Research of PZD Inhibiting Lung Cancer Cell Proliferation, Invasion, and Migration based on Network Pharmacology
Journal:
Current Pharmaceutical Design
Volume:
30
Page:
1279-1293
Author(s):
Fan Feng*, Ping Hu, Lei Peng, Jun Chen and Xingkui Tao
CT109-SN-38, a Novel Antibody-drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells
Journal:
Current Cancer Drug Targets
Volume:
24
Page:
720-732
Author(s):
Kelly C. Arias Cardenas, Clinton W. Enos, Mark R. Spear*, Dana E. Austin, Raghad Almofeez, Stephanie Kortchak, Lauren Pincus, Hua-bei Guo, Samuel Dolezal, J. Michael Pierce, Emma Furth, Cyrille Gineste, Yongjun Kwon and Cohava Gelber
Preclinical Pharmacokinetics and Pharmacology Study of RC98: A Programmed Cell Death Ligand 1 Monoclonal Antibody in Cynomolgus Monkeys
Journal:
Current Pharmaceutical Design
Volume:
30
Page:
1240-1246
Author(s):
Ling Wang, Qiaoning Li, Chenglian Deng, Zhihao Liu, Fang Wang, Shenjun Li, Lihou Dong and Jing Jiang*